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Abstract
Vascular dysfunction is recognised as an integrative marker of CVD. While dietary strategies aimed at reducing CVD risk include reductions
in the intake of SFA, there are currently no clear guidelines on what should replace SFA. The purpose of this review was to assess the
evidence for the effects of total dietary fat and individual fatty acids (SFA, MUFA and n-6 PUFA) on vascular function, cellular microparticles
and endothelial progenitor cells. Medline was systematically searched from 1966 until November 2010. A total of fifty-nine peer-reviewed
publications (covering fifty-six studies), which included five epidemiological, eighteen dietary intervention and thirty-three test meal
studies, were identified. The findings from the epidemiological studies were inconclusive. The limited data available from dietary interven-
tion studies suggested a beneficial effect of low-fat diets on vascular reactivity, which was strongest when the comparator diet was high in
SFA, with a modest improvement in measures of vascular reactivity when high-fat, MUFA-rich diets were compared with SFA-rich diets.
There was consistent evidence from the test meal studies that high-fat meals have a detrimental effect on postprandial vascular function.
However, the evidence for the comparative effects of test meals rich in MUFA or n-6 PUFA with SFA on postprandial vascular function was
limited and inconclusive. The lack of studies with comparable within-study dietary fatty acid targets, a variety of different study designs and
different methods for determining vascular function all confound any clear conclusions on the impact of dietary fat and individual fatty
acids on vascular function.
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CVD remains the major cause of death in Western societies.
Although CVD is a multi-factorial disease, diet has been
shown to play an important role in both the development
and progression of the disease. Dietary strategies aimed at
reducing the incidence of CVD include the recommendation
to reduce SFA in the diet. In 1994, the Committee on Medical
Aspects of Food Policy (COMA) published a report on Nutri-
tional Aspects of CVD which included a recommendation to
reduce the average intake of SFA from 16 % to no more than
11 % of food energy. Although the dietary intake of SFA has
fallen, current intakes for 19–64-year-olds assessed in the
first year of the National Diet and Nutrition Survey (NDNS)
rolling programme (February 2008 to March 2009) exceed
the COMA recommendation, at approximately 12·8 % of food
energy(1); total fat intake at 35·1 % of dietary energy is at the
recommended level of intake for the population. A key ques-
tion that needs to be addressed is whether the further desired
reduction in SFA intake should be achieved through
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replacement of dietary fat with carbohydrate (low-fat diets), or
whether substitution of SFA with n-6 PUFA or MUFA is a more
desirable population target. There is evidence for potentially
detrimental metabolic effects of low-fat, high-carbohydrate
diets in some population groups, such as type 2 diabetics(2,3),
and it is argued that n-6 PUFA and MUFA substitution is pre-
ferable since both would achieve further reductions in LDL-
cholesterol that cannot be achieved with the removal of SFA
alone. However, the benefits of n-6 PUFA or MUFA substi-
tution compared with low-fat diets on new and emerging
risk factors for CVD, including vascular function, are unclear.
Therefore, it is timely to assess a wider body of evidence on
SFA substitution with fat of differing fatty acid profiles in an
attempt to inform and strengthen the evidence base for
public health recommendations of dietary SFA replacement.
Endothelial dysfunction is strongly associated with
increased CVD risk and has emerged as a critical early modifi-
able event in the development of coronary atherosclerosis(4).
Since endothelial dysfunction results from the collective
effects of both traditional (age, smoking, blood pressure and
lipid abnormalities) and emerging (genetic make-up, insulin
resistance and inflammation) risk factors, it offers considerable
utility as an integrated and early measure of the effects of diet
and lifestyle on CVD risk(5). Numerous studies have high-
lighted the prognostic value of in vivo measures of vascular
reactivity, of both the coronary and peripheral arteries, in pre-
dicting future coronary events(4,6). Although there is currently
no ‘gold-standard’ technique for measuring vascular function,
flow-mediated dilatation (FMD) involving post-ischaemic wall
tracking of brachial artery dilatation by ultrasound has been
extensively used as a surrogate marker of coronary vascular
function(7). Other techniques include measurement of forearm
blood flow (FBF) in response to vasoactive substances using
strain gauge plethysmography(8) and laser Doppler imaging
with iontophoresis (LDI), a non-invasive technique to assess
endothelial function in the peripheral microcirculation(9,10).
Arterial stiffness is commonly measured as an estimate of the
elasticity of the vessels and has been associated with athero-
sclerosis and CVD incidence(11). Methods for the measurement
of arterial stiffness include pulse wave analysis (PWA), pulse
wave velocity (PWV) and digital volume pulse (DVP).
The relationships between traditional markers of endo-
thelial function, such as von Willebrand factor and adhesion
molecules, have been well described in the literature(12–14),
and reviewed in relation to dietary fat intake(15–19). In con-
trast, while endothelial progenitor cells and microparticles
are now recognised as potential novel biomarkers of vascular
function, there is still only limited data on the impact of dietary
fat and fatty acid intake on their circulating levels(20). Endo-
thelial progenitor cells originate in the bone marrow and are
seen in small numbers in healthy individuals, but tend to
increase following vascular injury(21). This increase has been
suggested to be related to angiogenesis, repair and mainten-
ance of the integrity of existing vessel walls(22). In addition
to the classical risk factors, emerging risk factors linked to
inflammation and vascular reactivity (as assessed by FMD)
have been associated with endothelial progenitor cell
number and/or function(23,24). Endothelial microparticles are
small vesicles that are released from endothelial cells and
can be found circulating in the blood. Several studies have
shown raised levels of endothelial microparticles, and in
some cases platelet microparticles, to be associated with endo-
thelial dysfunction and obesity(25–27).
The effects of substituting SFA with MUFA and n-6 PUFA on
plasma lipid levels and inflammatory biomarkers have been
extensively studied, yet the influence of these dietary manip-
ulations on vascular function remains unclear. Therefore, the
main scientific question in this review addressed the effects
of total dietary fat and individual fatty acids (SFA, MUFA and
n-6 PUFA) on vascular function, cellular microparticles and
endothelial progenitor cells by critically evaluating the existing
evidence from epidemiological, human dietary intervention
and postprandial test meal studies of the quantity and quality
of dietary fat (SFA, MUFA and n-6 PUFA) on vascular function,
endothelial progenitor cells and microparticles. The impact of
n-3 PUFA, in particular long-chain n-3 PUFA (DHA and EPA),
on vascular function has not been specifically addressed in
this instance due to the number of reviews that already exist
in this subject area(15,19,28). Nevertheless, the importance of
long-chain n-3 PUFA as a dietary strategy to reduce CVD inci-
dence and mortality should not be underestimated since its
consumption is associated with a lower risk of CVD develop-
ment(29,30), blood pressure and vascular function(31,32).
Subjects and methods
A systematic approach was used to identify all relevant pub-
lished literature. Database searching was performed exclu-
sively using the Medline database (US National Library of
Medicine, Bethesda, MD, USA) following a similar approach
to Dangour et al.(33). The search period covered all studies
published in English until November 2010. A protocol that
specified the method in which to conduct the literature
search was initially prepared and agreed by the review
team. The search strategy consisted of an initial identification
of relevant search terms for exposures (which included
descriptors of SFA, MUFA and n-6 PUFA, and relevant food
sources) and outcomes (which included descriptors of vascu-
lar function). The Medical Subject Heading Browser (http://
www.nlm.nih.gov/mesh/MBrowser.html) was used to identify
relevant Medical Subject Heading descriptors that were
included in the search strategy as terms and combined with
a list of relevant outcome terms. The Scientific Advisory Com-
mittee on Nutrition Framework for the Evaluation of Evidence
that Relates Food and Nutrients to Health(34) was used as a
basis to identify and assess evidence on the effects of dietary
fats on vascular function. The titles and abstracts of all papers
were assessed for relevance by three reviewers. The evidence
base of this review is restricted to epidemiological (cross-
sectional and cohort) and randomised controlled trials in
human subjects with respect to total fat, SFA, MUFA and/or
n-6 PUFA intake and measures of vascular function, as well
as novel circulating biomarkers of vascular function, micro-
particles and endothelial progenitor cells. Data from animal
and in vitro studies were collated, but not included in the
review. In addition, studies or results on the effects of total
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fat, SFA, MUFA and/or n-6 PUFA on blood pressure and
other traditional biomarkers of vascular dysfunction (such as
von Willebrand factor and cell adhesion molecules) were not
included since these have been reviewed elsewhere(15,35,36).
Only published peer-reviewed literature was accepted,
whereas ‘grey’ literature, such as dissertations, conference
proceedings, reports, letters to editors and other non-
peer-reviewed research, were excluded. Relevant reviews
were collated but not included in the review. Hand-searching
was performed on the reference lists of review articles to
confirm the completeness of initial electronic searches. All
researchers agreed on a common data extraction procedure.
Extracted data included all study characteristics such as
study type and design, volunteers’ characteristics, type of
dietary intervention, type/amount of fatty acids incorporated
in the diet, any vascular function outcomes and statistical
significance. Data extraction was performed in duplicate by
two reviewers for the first ten publications and the extracted
data were compared for any inconsistencies.
Evidence from both epidemiological studies and randomised
controlled trials is generally included in the evaluation process
of the relationship between diet and health. Although
epidemiological studies can offer informative data on possible
associations between environmental exposures, such as dietary
components, and mortality, morbidity, disease risk or bio-
markers of risk, cause and effect cannot be determined.
These studies have been of paramount importance in hypoth-
esis generation, yet consideration of significant confounding
factors in such studies is essential. In comparison, randomised
controlled trials are considered the ‘gold standard’ in terms of
the strength of the scientific evidence supporting dietary rec-
ommendations for populations. Long-term controlled dietary
intervention studies in free-living populations are well recog-
nised to be highly demanding, particularly when the study
requires changes to a major component of the diet, such as diet-
ary fat content and/or quality, but these studies are very infor-
mative. In addition to the importance of the chronic impact of
different diets, it is becoming increasingly apparent that since
individuals spend the majority of the day (approximately
18 h) in the postprandial state, determination of the metabolic
effects after the ingestion of a meal is of greater physiological
relevance than the post-absorptive, fasting state. In 2007, two
prospective cohort studies reported postprandial, non-fasting
plasma TAG concentrations to be an independent risk factor
for CVD, further adding weight to the argument that the
postprandial phase is an important factor in relation to
cardiovascular health(37,38). Postprandial test meal studies
provide information on the daily stress imposed on the endo-
thelium by exposure to post-meal levels of metabolites such
as lipids, glucose and insulin, therefore enabling the determi-
nation of the optimal amount and type of fat in the meal that
have beneficial effects on vascular health.
Due to the small number of relevant studies and the large
heterogeneity in study design, time of exposure, measures
of vascular function and types of statistical analysis, a formal
meta-analysis could not be performed. Therefore, a qualitative
systematic approach was undertaken to search and evaluate
the literature.
Results and discussion
The literature search identified 4687 publications in total.
From these studies, we identified fifty-nine relevant articles
describing fifty-six studies that examined the effects of total
fat and/or SFA and/or MUFA and/or n-6 PUFA on vascular
function, endothelial progenitor cells and microparticles.
These included six publications describing five epidemio-
logical studies, eighteen publications describing the equivalent
number of long-term dietary intervention studies and thirty-five
publications describing thirty-three postprandial test meal
studies. Data from these human studies will be presented in
two sections; the first addressing total fat quantity and the
second, the effects of individual fatty acids.
Effects of dietary fat quantity on vascular function
Epidemiological associations from cross-sectional and
cohort studies
Of the two studies identified in the literature, inconsistent find-
ings were observed in the cross-sectional(39) and longitudinal
cohort(40) studies, both conducted in children (Table 1).
Schack-Nielsen et al.(40) reported a significant positive
relationship between total energy from fat (estimated from
7 d diet diaries) and arterial stiffness measured by PWV
(aorto-radial: correlation coefficient (r) 0·32 (P¼0·004) and
aorto-femoral: r 0·20 (P¼0·051)) in healthy Danish children
followed up at the age of 10 years. However, no association
between total fat intake and arterial compliance was observed
by Schutte et al.(39) in South African children aged 10–15
years. The atherosclerotic process that is normally exacerbated
by an impaired endothelium function begins early in child-
hood(41,42). Furthermore, there is evidence to suggest that
the presence of atherosclerotic risk factors in childhood is
predictive of CVD risk later in life(43). Therefore, although
the evidence is not conclusive, future nutritional studies in
children may provide valuable information about the effect
of dietary fat intake at early stages in life on the prevention
of CVD development in adulthood.
Dietary intervention studies investigating dietary fat intake
Details of the thirteen studies, identified between 1997 and
2010, which examined the effects of a low-fat diet only or
compared diets of differing fat contents, are presented in
Table 2. In two studies, low-fat diets were associated with
an improvement in vascular function when compared with
baseline(44,45), while six studies showed that low-fat diets
either improved(46–48) or attenuated the reduction in vascular
function observed with high-fat diets(49–51). Conversely, two
studies that compared the postprandial vascular responses to
test meals representative of the previous intervention diet
reported the high-fat diets to have beneficial effects(52,53).
However, with this type of study design, it is not possible to
conclude whether the responses observed reflect the effects
of the long-term dietary intervention, since differences have
been observed with test meals of differing fatty acid compo-
sition(54), independent of background diet.
Dietary fatty acids and vascular function 305
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Overall, there is weak evidence to suggest that low-fat diets
have beneficial effects on vascular function. However, the
evidence becomes stronger when the fatty acid composition
of the intervention diets is taken into consideration. Of the
seven studies comparing low-fat (,30 percentage of energy
(%E) total fat) with high-fat, SFA-rich (29·7–35·9 %E total fat)
diets, three reported an improvement in vascular function
with the low-fat diet(46–48), whereas two studies showed a
low-fat diet to attenuate the decline in vascular function
observed with the high-fat, SFA-rich diet(49,51). In addition, a
further study reported an improvement in arterial stiffness
with a low-fat (30 %E), low-cholesterol (,200 mg/d) diet,
which followed a habitual diet high in SFA(45). Nestel
et al.(47) reported that the fatty acid composition of a low-fat
diet (26 %E) may influence the improvement in arterial elas-
ticity relative to high-fat diets (46·9–50·7 %E). In overweight/
obese men and postmenopausal women, a low-fat, PUFA-
rich diet led to a significantly greater improvement in arterial
elasticity, with only a tendency for an improvement with a
low-fat, MUFA-rich diet, which did not reach statistical signifi-
cance. Interestingly, in studies that incorporated a dietary
intervention and test meal challenge, a high-fat (38 %E), SFA-
rich diet and test meal showed a similar postprandial vascular
response (measured by ischaemic reactive hyperaemia) to the
low-fat (,30 %E) diet and low-fat test meal(52,53). In addition
to these studies, Keogh et al.(44) found no change in FMD,
but an improvement in PWV relative to baseline, 8 weeks
after two weight-loss diets, a high-fat (61 %E), SFA-rich,
low-carbohydrate Atkins diet or a low-fat (30 %E), high-
carbohydrate diet, in obese adults. A further study by this
group(51) revealed that the consumption of identical diets for
1 year led to an impairment in FMD with the high-fat, SFA-
rich, low-carbohydrate diet, whereas PWV was shown to be
improved following both diets. The significant weight loss in
these two groups of obese subjects after ingestion of the
diets for 8 weeks(44) and 52 weeks(51) (7·5 and 14·9 kg,
respectively) was thought to contribute to the improvement
in PWV as opposed to the differences in dietary fat intake.
Of the five studies that compared the effects of a low-fat diet
(18–28 %E) relative to a high-fat (37–44 %E), MUFA-rich diet,
three showed no significant effect of dietary fat con-
tent(49,55,56), whereas two studies reported beneficial effects
on postprandial vascular function with a high-fat, MUFA-rich
diet and test meal compared with a low-fat diet and test
meal(52,53). However, while these data provide support for
acute beneficial effects of MUFA-rich test meals, it cannot be
concluded that these responses were dependent on the
MUFA-rich background diet, since comparisons of the
responses to the MUFA-rich test meal following background
diets of differing fat content and composition were not
made. Keogh et al.(49) suggested that even though the
amounts of dietary fat in the high-fat, SFA-rich and high-fat,
MUFA-rich diets were identical (36–37 %E), only the high-
fat, SFA-rich diet reduced the FMD response relative to the
low-fat (18 %E) and high-fat, MUFA-rich diet after 8 weeks in
healthy adults(49). This finding highlights the importance of
the fatty acid composition of the high-fat diet on vascularT
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Table 2. Chronic dietary intervention studies investigating the effects of total dietary fat on vascular function in healthy and non-healthy volunteers
Reference
Subject group,
age and n (M/F)
Study design
and duration
Description of dietary
intervention (total fat, %E)
Dietary fat composition (%E, unless specified)
Vascular
function
measure Significant outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Healthy volunteers
Ashton et al. (2000)(55) 35–55 years (M) and
50–60 years (PMW)
n 28 (14/14)
CO, R
4 weeks per diet
HF, MUFA-rich diet (40–42 %E) 7–8 26–28 7–8* CHO: 40–45 mg/d;
Chol: 112 mg/d
Arterial
elasticity
NS
LF, high CHO diet (22–25 %E) 7–8 7–8 7–8* CHO: 55–60 mg/d;
Chol: 103 mg/d
de Roos et al. (2001)(106) 19–59 years CO, R, C LF, high CHO diet (25·7 %E) 10·3 7·8 6·9* CHO: 59·7 mg/d;
Chol: 294 mg/d
FMD NS
n 32 (11/21)
3·5 weeks per diet
HF, MUFA diet (44·4 %E) 15·5 19·3 8·8* CHO: 37·8 mg/d;
Chol: 386 mg/d
Raitakari et al. (2005)(48) Infants (7 months old),
followed up at 11 years
n 369 (182/187)
PAL, R, C LF, low SFA diet (about 30 %E) Boys: 10·8 ND ND FMD " LF, low SFA v.
control diet
(P¼0·003) in
boys only
Girls: 11·5 ND ND10·5 years
Control diet (ND) Boys: 13·2 ND ND
Girls: 12·8 ND ND
Keogh et al. (2005)(49) 20–75 years
n 40 (19/21)
CO, R
3 weeks per diet
HF, SFA-rich diet (37 %E) 19 12 4* CHO: 45 mg/d;
Chol: 326·5 mg/d
FMD # HF, SFA-rich v. HF,
MUFA-rich, HF,
PUFA-rich and LF,
high CHO diets
(P¼0·01)
HF, MUFA-rich diet (37 %E) 8 19 7* CHO: 44 mg/d;
Chol: 206·9 mg/d
HF, PUFA-rich diet (36 %E) 9 10 15* CHO: 45 mg/d;
Chol: 174·3 mg/d PWV NS
LF, high CHO diet (18 %E) 7 6 3* CHO: 65 mg/d;
Chol: 167·3 mg/d
Fuentes et al. (2008)(52)
(chronic and acute study)
Apo E3/E3 genotype
18–30 years
n 20 (20/0)
CO, R, C
4 weeks per diet
Chronic diets and acute
test meal:
IRH # SFA-rich and LF
ALNA-rich meals at 4
(P¼0·031) and 6 h
(P¼0·013) v.
MUFA-rich meal
HF, SFA-rich Western diet
(38 %E)
22 12 4* ALNA: 0·4 %E
SFA-rich meal (60 %E) 35 22 4* ALNA: 0·7 %E
HF, MUFA-rich Mediterranean
diet (38 %E)
,10 24 4* ALNA: 0·4 %E Total nitrites " fasting level with HF,
MUFA-rich v. HF,
SFA-rich (P,0·05)
or LF, ALNA-rich
diets (P,0·05)
MUFA-rich meal (60 %E) 22 38 4* ALNA: 0·7 %E
LF, ALNA-rich diet (,30 %E) ,10 12 8* ALNA: 2 %E
ALNA-rich meal (60 %E) 20 24 16* ALNA: 4 %E
Miller et al. (2009)(46) .20 years Mean age
30·6 ^ 9·6 years
n 18 (9/9)
CO, R
4 weeks per diet
HF, low CHO Atkins diet
(29·7 %E†)
15·4† ND ND Chol: 567 mg/d FMD " Ornish v. Atkins
diet (P value ND)
Mediterranean South Beach diet
(17·0 %E†)
7·7† ND ND Chol: 202 mg/d
LF, high CHO Ornish diet
(4·9 %E†)
1·6† ND ND Chol: 114 mg/d
Non-healthy volunteers
Nestel et al. (1997)(47) OB and OW (BMI
25–36 kg/m2)
C
4 weeks per diet
% total fat % total fat % total fat Arterial
elasticity
" LF-MUFA-rich
v. HF-S1
diet (P,0·05)Mean age
54 ^ 6 years
n 15 (8/7)
(PMW)
HF, SFA-rich diet 1
(HF-S1) (35·9 %E)
50·7 35·3 14·3* CHO: 42·5 mg/d;
Chol: 295 mg/d
" LF-ALNA-rich v.
HF-S1 (P,0·0001),
HF-S2 (P,0·005)
and LF-MUFA-rich
(P,0·05) diets
LF, MUFA-rich diet
(26·4 %E)
25·8 58·1 16·1* CHO: 57·9 mg/d;
Chol: 206 mg/d
LF, ALNA-rich diet
(26·3 %E)
23·4 27·5 49·1* CHO: 58·4 mg/d;
Chol: 210 mg/d
HF, SFA diet 2
(HF-S2) (34·7 %E)
46·9 36·2 16·4* CHO: 46·6 mg/d;
Chol: 287 mg/d
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Table 2. Continued
Reference
Subject group,
age and n (M/F)
Study design
and duration
Description of dietary
intervention (total fat, %E)
Dietary fat composition (%E, unless specified)
Vascular
function
measure Significant outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Fuentes et al. (2001)(56) Caucasian HC (plasma
Chol .5·2 mmol/l)
aged 18–65 years
n 22 (22/0)
CO, R, C
4 weeks per diet
HF, SFA-rich diet
(run-in diet) (38 %E)
20 12 6* CHO: 47 FMD " HF, MUFA-rich v.
HF, SFA-rich diet
(P¼0·027)LF, high CHO diet (28 %E) ,10 12 6* CHO: 57
HF, MUFA-rich diet (38 %E) ,10 22 6* CHO: 47
Pirro et al. (2004)(45) HC (LDL .4·1 mmol/l)
Mean age
58 ^ 4 years
n 35
UC
8 weeks
LF diet (low Chol and low
SFA) (30 %E)
5 ND ND Chol: ,200 mg/d PWV # LF diet v. baseline
(P¼0·02)
Keogh et al. (2008)(44) OW and OB (BMI
27–44 kg/m2)
Abdominally obese
and $1 extra
risk factor for MS
24–64 years
n 66
PAL, R, C
8 weeks
Energy-restricted diets: FMD NS
HF, very low CHO diet
(HF) (61 %E) 20 ND ND
CHO: 4
LF, high CHO diet (LF) (30 %E) ,8 ND ND CHO: 46 PWV # HF, low-CHO and LF,
high-CHO diets v.
baseline (both
P,0·001)
Estimate from 12 d food diaries:
HF (58·5 %E) 21 25 8*
CHO: 5·1 mg/d;
Chol: 598 mg/d
LF (27·8 %E) 6 12 7* CHO: 46·7 mg/d;
Chol: 140 mg/d
Bradley et al. (2009)(50) OW and OB (mean BMI
33·6 ^ 3·7 kg/m2)
Mean age
39 ^ 10 years
n 24 (9/15)
PAL, R, C
8 weeks
Energy-restricted diets:
# LF, high CHO diet v.
HF, low CHO diet
(P¼0·04)
HF, low CHO (60 %E) ND ND ND CHO: 20 PWA
LF, high CHO (20 %E) ND ND ND CHO: 60
Perez-Martinez et al.
(2009)(53) (chronic
and acute study)
MS
35–70 years
n 74
PAL, R, C
12 weeks
Chronic diet and acute test meal: LC n-3 PUFA
(g/d or g/meal)
IRH " IRH 4 h after HF,
MUFA-rich v.
other diets (P,0·05)HF, SFA-rich diet (38 %E) 16 12 6* 0
HF, SFA-rich meal (65 g) 38 21 6* 0
HF, MUFA-rich diet (38 %E) 8 20 6* 0
HF, MUFA-rich meal (65 g) 12 43 10* 0
Total nitrites NS
LF, high CHO diet and n-3 PUFA
(LFHCC n-3) (28 %E) 8 11 6*
1·24
LFHCC n-3 PUFA-rich meal (65 g) 21 28 16* 1·24
NO synthaseLF, high CHO diet and high oleic
sunflower-seed oil (LFHCC)
(28 %E) 8 11 6* 0
" NO synthase 4 h
after HF, MUFA-rich
v. HF, SFA-rich and
LFHCC diets
(P¼0·035)LFHCC meal (65 g) 21 28 16* 0
K
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function, which will be discussed in more detail in the second
part of this review.
In the study by Ashton et al.(55), no differences were
observed between the high-fat (40–42 %E), MUFA-rich and
low-fat (22–25 %E) diets, but it was unclear whether improve-
ments in arterial elasticity were observed in response to both
diets as baseline values were unavailable. Bradley et al.(50)
compared two weight-loss regimens, one a high-fat, low-
carbohydrate (60 % fat; 20 % carbohydrate) diet containing
equal proportions of SFA (21 %E) and MUFA (21 %E), and
the other a low-fat, high-carbohydrate (20 % fat; 60 % carbo-
hydrate) diet. After 8 weeks, the low-fat diet was shown to
improve the aortic augmentation index (arterial stiffness) in
overweight and obese subjects compared with the high-fat
diet. Only one study, conducted in healthy adults, has com-
pared the effects of a high-fat (36 %E), PUFA-rich diet (type
of PUFA not reported) v. a low-fat (18 %E) diet(49), but no
differences were observed in vascular function, assessed
using FMD and PWV, between the diets (Table 2).
Effects of meal fat quantity on postprandial vascular
function
Substantial differences in study design were observed
between the twenty test meal studies published between
1996 and 2010 (Table 3). These included differences in the
type of test meal (for example, fat-containing drinks v.
mixed meals), meal fat content, frequency of blood sampling
during the postprandial period and vascular function out-
comes. Of the twenty studies, eight examined the effects of
high-fat meals only without including a comparator meal in
their design(57–64), whereas the remaining twelve studies
compared high-fat with low-fat meals(65–76).
Irrespective of the differences in study design, the majority
of the studies in healthy volunteers reported a clear impair-
ment in postprandial vascular function following a high-fat
meal (36–80 g fat). The only study to report no effect(71)
was conducted in eight young adults and may have been con-
founded by the small sample size and failing to control for the
menstrual cycle in women, a factor known to influence FMD
measurements(77). It should also be highlighted that although
there were no significant changes from baseline following the
high-fat meal in this study, the endpoint measure of FMD was
significantly higher after the low-fat meal (0 g fat) compared
with the high-fat (48 g fat) meal(71). In contrast, Phillips
et al.(76) reported an improvement in arterial stiffness in
healthy, obese and type 2 diabetic subjects 6 h after a high-
fat meal, with the return to baseline levels of arterial stiffness
shown to be delayed in type 2 diabetics (297 min from base-
line) compared with healthy subjects (161 min from baseline).
Interestingly, in two studies, similar vascular responses to a
high-fat meal were observed in both lean and obese sub-
jects(63,76), leading the authors to conclude that alterations in
postprandial vascular reactivity may be unlikely to contribute
to the increased CVD risk in obese adults(63).
Similar deleterious effects of high-fat meals on vascular
function were reported in three studies that included type 2
diabetic subjects(58,61,64). In one of these studies, the vascularTa
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Table 3. Acute test meal studies investigating the effects of meal fat content on vascular function in healthy and non-healthy subjects
Reference
Subject group,
age and n (M/F)
Study
design
Description of test meal
(total fat, g or %E)
Fatty acid composition of test meal (g or %E)
Vascular function
measure
(time points) Significant outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Healthy subjects
Plotnick et al.
(1997)(67)
24–54 years
n 20 (7/13)
CO, R, C HF meal (50 g) ND ND ND Chol: 255 mg; VitC:
1000 mg
FMD (0, 2, 4 and 6 h) # 2, 3 and 4 h after HF meal
LF meal (0 g) ND ND ND Chol: 13 mg; VitC:
1000 mg
Vogel et al.
(1997)(69)
39 ^ 10 years
n 10 (5/5)
CO, R, C HF meal (50 g) 14 g ND ND Chol: 255 mg FMD (0, 1, 2, 3, 4, 5
and 6 h)
# 2 (P¼0·05), 3 (P¼0·02)
and 4 h (P¼0·03) after
HF v. LF meal
LF meal (0 g) 14 g ND ND Chol: 13 mg
Ong et al. (1999)(66) 30 ^ 5 years
n 16 (16/0)
CO, R, C HF meal (50 g) 4 g 38 g 5 g CHO: 48 g FMD (0 and 3 h) # HF than LF/H-CHO
meal (P¼0·02)LF/H-CHO meal (5 g) 0·4 g 3·8 g 0·5 g CHO: 218 g
Marchesi et al.
(2000)(59)
21–25 years
n 10 (10/0)
UC HF meal (65 g) ND ND ND CHO: 25 g FMD (2, 4, 6 and 8 h) # HF meal at 2 (P,0·05)
and 4 h (P,0·05) only
Gaenzer et al.
(2001)(60)
29–43 years
n 17 (17/0)
R, C HF drink (65 g/m2 BSA) 41 g 20 4 CHO: 24 g;
Chol: 240 mg
EDV (4 and 8 h) Fasting EDV showed a
diurnal variation (P,0·001).
EDV at 4 h (12·00) less
than fasting EDV at 12.00
hours (P¼0·027) and
correlated inversely with the
magnitude of postprandial
triacylglycerolaemia
(8 h TAG AUC)
(r 20·81, P,0·001)
Ng et al. (2001)(65) Chinese students
aged 22 ^ 2 years
n 10 (10/0)
CO, R, C Asian HF meal (50 g) 40 g ND ND Chol: 255 mg FMD (0, 4 h) # Western and Asian HF
meals v. LF meal (P,0·006,
P,0·001, respectively)
Western HF meal (50 g) 14 g ND ND Chol: 255 mg
LF meal (0 g) 0 g ND ND Chol: 0 mg
Sarabi et al.
(2001)(68)
n 10 (10/0) C HF meal (34 %E) 26 % fat 38 % fat 36 % fat* CHO: 51 %E FBF (0, 1 and 2 h) # EDV 1 h after HF meal
(P,0·001) and return
to fasting levels at 2 h
(P,0·001 v. 1 h)
Fat-free meal 0 0 0
Healthy subjects
Bae et al. (2003)(70) 25–27 years
n 10 (10/0)
CO, R, C HF meal (53·4 g) ND ND ND CHO: 50 g FMD (0, 2, 4 and 6 h) # 2 and 4 h after HF
meal v. baseline
(P,0·05) and LF
meal (P,0·001)
LF meal (3 g) ND ND ND CHO: 178 g
Steer et al. (2003)(73) 20–30 years
n 26 (13/13)
PAL, R, C CHO/Trans FA/VitCWestern HF meal
(34 %E) 8·9† %E 12·9† %E ND 51 %E/12·3 %E/147 mg FBF (0, 1 and 2 h) # EDV (P,0·01)
1 h after HF meal
" EDV (P,0·01)
1 h after MF meal
LF meal (20 %E) 6† %E 7·4† %E ND 66 %E/6·6 %E/78 mg
MF meal (3 %E) 0·9† %E 0·5† %E ND 84 %E/1·7 %E/114 mg
Tsai et al. (2004)(57) 21–39 years
n 16 (16/0)
UC HF meal (50 g) 14 g ND ND Chol: 225 mg FMD (0, 2, 4 and 6 h) # 2, 4 and 6 h after HF
meal v. baseline
(P,0·001)
Padilla et al.
(2006)(71)
26 ^ 1 years
n 8 (5/3)
CO, C CHO/Trans FA/Chol
LF meal (0 g) 0 g ND ND 209 g/0 g/5 mg FMD (0 and 4 h) " after LF v. HF meal
(P¼0·001)HF meal (48 g) 16·5 g ND ND 91 g/4·5 g/280 mg
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Table 3. Continued
Reference
Subject group,
age and n (M/F)
Study
design
Description of test meal
(total fat, g or %E)
Fatty acid composition of test meal (g or %E)
Vascular function
measure
(time points) Significant outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Tushuizen et al.
(2006)(62)
Caucasian aged
20–35 years
n 17 (17/0)
CO, R, C Two consecutive
HF meals at
breakfast (0 h)
and lunch (4 h)
(50 g each)
60 % of
fat (14 g)
ND ND CHO: 55 g FMD (0, 2, 4, 6 and 8 h) # 6 h after HF meal v.
baseline (P,0·05)
Water only 0 g 0 g 0 g CHO: 0 g
Shimabukuro et al.
(2007)(72)
30–42 years
n 12 (6/6)
CO, R, C High-CHO meal
(0 %E)
ND ND ND CHO: 100 %E FBF (0, 2 and 4 h) Peak FBF and total reactive
hyperaemic flow #
2 and 4 h after HF meal
(P,0·01)
HF meal (35 %E) ND ND ND CHO: 0 %E
Standard meal
(control; 32·7 %E) ND ND ND CHO: 50·4 %E
Bui et al. (2010)(75) Asian aged
26·4 ^ 4·2 years
n 11 (11/0)
CO, R HF meal (50·1 g fat) 14 g ND ND CHO: 43·8 g; Chol:
443 mg
FBF (2 and 4 h) Compared with LF meal,
FBF # with HF meal
in Asians only (P¼0·02)
FBF attenuated in Asians
compared with Caucasians
(19·3 %, P¼0·09)
Caucasian aged
26·8 ^ 4·6 years
n 8 (8/0)
LF meal (5·1 g fat) 1 g ND ND CHO: 135·8 g;
Chol: 0 mg
Healthy and
non-healthy
subjects
Anderson et al.
(2001)(58)
T2D aged 35–53 years
n 12 (7/5)
PAL Standard fat-
containing drink
80 g ND ND FMD (0 and 4 h) # in control and T2D patients
v. baseline (P,0·05)
Healthy controls
aged 30–63 years
n 12 (5/7)
# in T2D patients at baseline
and 4 h v. controls (P,0·05)
Tushuizen et al.
(2007)(61)
Caucasian T2D (n 15)
and Caucasian healthy
controls (n 12)
PAL Three isoenergetic
meals (0, 4 and 8 h)
(50 g)
60 % total
fat
ND ND CHO: 75 g FMD (0, 2, 4, 6, 8,
12, 16, 20 and 24 h)
# in T2D v. healthy
group (P,0·01) at baseline
Mean age 55 ^ 2 years
n 27 (27/0)
Over 24 h, # in both groups
# in T2D group v. healthy
group (P,0·01)
Tousoulis et al.
(2010)(74)
Young adults
n 37 (26/11)
PAL, R Extra virgin olive oil
(45·8 g)
6·4 g 35·3 g 4·2 g* FBF (0, 1, 2 and 3 h) # 1 h after maize oil v.
baseline and water
control (P,0·05)Maize oil (46 g) 6 g 12·5 g 27·5 g*
" 1 h after soya oil v.
baseline and water
control (P,0·05)
Soya oil (46 g) 7 g 11·5 g 27·5 g*
Water control 0 g 0 g 0 g
Ayer et al. (2010)(63) Obese (n 11) and
healthy controls (n 11)
aged 22 ^ 6 years
n 22 (22/8)
PAL HF meal (60 g) made
of coconut oil (24 g),
olive oil (24 g) and
sunflower-seed
oil (12 g)
25·2 g† 21·4 g† 10 g†* FMD
FBF
PWV
PWA
DVP
(0, 1 and 3 h)
NS
NS
NS
NS
NS
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response to three consecutive high-fat meals (50 g fat) was
impaired to a greater extent in type 2 diabetics compared
with healthy control subjects(61), suggesting that individuals
with increased CVD risk may handle fat differently during
the postprandial phase (Table 3).
The findings from studies that investigated the effects of
high-fat v. low-fat meals support the hypothesis that ingestion
of a high-fat meal leads to an impairment of vascular function.
Only one study has attempted to examine the dose-dependent
effect of increasing the test meal fat content on postprandial
vascular function. Steer et al.(73) reported a decrease in the
FMD response with a high-fat meal (34 %E) only, with little
effect of moderate (20 %E) or minimal (3 %E) fat meals.
There is also limited evidence relating to the maximum
amount of dietary fat, ingested in a single sitting that can influ-
ence FMD or other vascular measures. This may vary with
health status, since the activation of the endothelial response
appears to be related to, among other factors, the degree of
elevation in circulating plasma TAG levels(59,60,76), which are
known to be significantly higher in subjects with type 2
diabetes and those at risk of CVD (for example, metabolic
syndrome)(78). Of the studies that examined the effect of a
single high-fat meal, four showed a fat-induced impairment
in vascular function when the meals were rich in SFA(57–59,64),
with three further studies reporting an impairment in vascular
function after sequential ingestion of both two(60,62) and
three(61) high-fat, SFA-rich meals.
There were two studies in which the high-fat meal (50 g fat)
was MUFA-rich(66,74). While a test meal enriched with high-
oleic sunflower-seed oil was shown to decrease the postpran-
dial FMD response compared with the baseline and low-fat
meal (5 g fat)(66), 50 g of extra-virgin olive oil were found to
have no effect on reactive hyperaemia compared with
water(74). In the latter study, the change in reactive hyper-
aemia from baseline at 1 h was lower after maize oil, but
higher after soya oil. This finding suggests that the type of
fat given in the high-fat test meal, and especially the PUFA-
rich meal, may have differential effects on postprandial vascu-
lar function when compared with water. The effect of fat
quality on postprandial vascular function will be discussed
in the second part of this review.
The impact of ethnicity on the postprandial vascular
response to a high-fat (50·1 g fat) v. a low-fat (5·1 g fat) meal
has been studied by Bui et al.(75). Although there was a
tendency for FBF to be attenuated in healthy Asian males
compared with Caucasian males after the high-fat meal,
Asian males were more sensitive to the fat content of the
test meals. In this group, the FBF was greater after the low-
fat meal (336·9 ml/100 ml tissue per min) compared with the
high-fat meal (287·4 ml/100 ml tissue per min), suggesting
that genetic differences between the ethnic groups may have
contributed to the variation in response to the test meals.
Effects of meal fat quantity on cellular microparticle
number
Only five studies were published between 2004 and
2010(61,62,79–81), three of which studied the effects of mealTa
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fat content on endothelial microparticles(61,79,80): two studies
on total microparticles(61,62) and another on platelet micropar-
ticles(81). A summary of these studies is presented in Table 4.
All of these studies were consistent in reporting a significant
increase in circulating microparticle number following a high-
fat meal (50–100 g fat), both in healthy subjects and those at a
higher CVD risk, suggesting that a high-fat meal may be
associated with vascular injury. In healthy volunteers, all
three studies reported an increase in circulating endo-
thelial(79,80) or platelet-derived microparticles(62) following a
high-fat meal. Although the complete fatty acid profiles of
the high-fat meals were not reported in these studies, two
stated that SFA contributed 28 % of total fat, suggesting that
SFA accounted for the deleterious effects on the vascular
wall. In the study by Ferreira et al.(79), the high-fat meal also
contained higher cholesterol levels compared with the low-
fat meal (255 v. 5 mg). However, two studies have reported
that daily egg consumption, equivalent to approximately
200 mg of dietary cholesterol, had little impact on endothelial
function in both healthy(82) and hyperlipidaemic adults(83),
suggesting that differences in the SFA content of the high-fat
(14 g) and low-fat meals (0 g) in the Ferreira study(79) may
have been responsible for the observed effects on FMD.
Studies on the effects of meal fat content on microparticles
in non-healthy volunteers showed similar increases in circulat-
ing numbers of cellular microparticles in both type 2 diabetics
and patients with established ultrasound-assessed athero-
sclerotic plaques(61,81). Tushuizen et al.(61) reported a greater
increase in cellular microparticle levels following consecutive
high-fat meals (50 g fat each) in type 2 diabetics than in
healthy controls. However, Michelsen et al.(81) showed no
difference in response to a high-fat meal (70 %E fat) between
healthy individuals and patients with established atherosclero-
tic plaques. These data strongly suggest that there may be
differences in cellular microparticle response to high-fat
meals between healthy populations and those at high CVD
risk, which warrants further investigation.
Summary
The outcomes of epidemiological (cross-sectional and cohort)
and dietary intervention studies have been inconsistent,
making it difficult to draw clear conclusions with respect to
the long-term effects of dietary fat quantity on vascular func-
tion. However, there does appear to be modest evidence for
a weak beneficial effect of low-fat diets, which was most
apparent when the comparator diet was high in SFA. It is
also worthy of note, that high-fat, MUFA-rich diets tend to
improve vascular function in a similar way to low-fat, high-
carbohydrate diets. Nevertheless, it should be taken into con-
sideration that when the MUFA-rich diets are based on virgin
olive oil, the reported beneficial effects on vascular function
may be mediated in part by its high phenolic content(84).
In comparison, evidence to support an association between
a high-fat meal and impairment of postprandial vascular func-
tion in both healthy subjects and in those with increased CVD
risk (for example, type 2 diabetics) is more consistent. There
are limited data to suggest that high-fat meals may modestly
increase the levels of circulating microparticles (a novel and
emerging biomarker of vascular function), with no data avail-
able on endothelial progenitor cells. However, data should be
viewed with caution since in the majority of the postprandial
studies, the fat content of the test meals was significantly
higher, and thus unrepresentative of an amount of fat nor-
mally ingested at a single sitting.
Effects of dietary fat quality on vascular function
Epidemiological associations from cross-sectional and
cohort studies
Of the five epidemiological studies (three cross-sectional
studies and two longitudinal cohort studies) published
between 2001 and 2010, two examined the relationship
between both dietary fat quantity and fatty acid quality with
vascular function(39,40) (see previous section and Table 1).
The remaining three (described in four publications) studied
associations between dietary fat composition and vascular
function (Table 5)(85–88). Significant associations between
fatty acid intake and vascular function were reported in the
three cross-sectional(39,85–87) and two longitudinal cohort
studies(40,88) (Tables 1 and 5). However, these studies had
limitations, including small sample sizes (n 56–174) and
sample population, with only one of the two cohort studies
being conducted in adults. There were also differing methods
of assessing dietary intake, including 24 h dietary recalls(39),
7 d intakes(40) or biomarkers of intake, such as serum
phospholipids(85), cholesteryl esters(85) and plasma/serum
fatty acids(87,88). The studies of Schutte et al.(39) and Sarabi
et al.(85) suggested that sex interactions may have masked
associations with vascular function, and that these interactions
warrant further attention. Furthermore, 24 h dietary recalls
were used to determine dietary intake, which, as a dietary
assessment tool that relies on memory, has major limitations
which could lead to inaccuracy.
There is a conflict in the associations between vascular func-
tion and different types of SFA in cross-sectional studies. The
study reported by both Sarabi et al.(85) and Lind et al.(86)
showed palmitic acid to be negatively associated (r 20·29;
P,0·05) with the endothelial function index (as assessed
by the ratio of endothelium-dependent vasodilation (EDV):
endothelium-independent vasodilation (EIDV)byvenousocclu-
sion plethysmography, reflecting the activity of endothelial NO
synthase), with stearic acid positively associated with the
endothelial function index (r 0·27; P,0·05) and FBF at recov-
ery after hyperaemia (r 0·41; P,0·01). Steer et al.(87) revealed
the total proportion of SFA, and in particular lauric and myris-
tic acid, to have a negative association with the endothelial
function index in healthy young men (r 20·37 and r 20·36
respectively, P,0·05), but not in women. In addition, Schutte
et al.(39) reported a negative association of SFA (regression
coefficient b ¼ –0·98; P¼0·008) and a positive association of
MUFA (b ¼ 1·34; P¼0·003) with pulse pressure in hyperten-
sive girls, whereas the intake of dietary PUFA was negatively
associated with pulse pressure (b ¼ –0·53; P¼0·007) in
hypertensive boys. Sarabi et al.(85) analysed associations
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Table 4. Acute test meal studies investigating the effects of meal fatty acids on microparticles in healthy and diseased subjects
Fatty acid composition of test meal (g or %E)
Reference Subject group, age and n (M/F)
Study
design
Description of test meal
(total fat, g or %E) SFA MUFA
n-6 PUFA
(PUFA*) Other
Vascular function
measure (time points) Significant outcomes
Fat quantity: healthy subjects
Ferreira et al. (2004)(79) Healthy aged 22–30 years
n 18 (10/8)
CO, UC LF meal (0 g) 0 g ND ND Chol: 5 mg EMP (0, 1 and 3 h) " 1 (P¼0·0007) and 3 h
(P,0·0001) after HF meal
HF meal (50 g) 14 g ND ND Chol: 255 mg " 1 (P¼0·001) and 3 h
(P,0·0001) after HF
v. LF meal
Tushuizen et al. (2006)(62) Healthy aged 20–35 years
n 17 (17/0)
CO, R, C Two consecutive
HF meals (50 g each) 14 g ND ND CHO: 55 g
Total MP (0, 2, 4, 6 and 8 h) " HF meal v. water
(P , 0·05)
Water only 0 g ND ND CHO: 0 g
Harrison et al. (2009)(80) Healthy aged 23–31 years
n 8 (8/0)
CO, R, C HF meal
(97 g fat/2 m2 BSA)
ND ND ND CHO: 124 g/2 m2 BSA EMP (0, 2, 4 and 6 h) " HF meals ^ exercise
(P¼0·05 for both)
Fat quantity: healthy
and non-healthy subjects
Tushuizen et al. (2007)(61) Caucasian uncomplicated T2D
(n 15) and healthy (n 12)
Aged 53–57 years
Total n 27 (27/0)
UC Three consecutive
isoenergetic meals
given at 0, 4 and
8 h (50 g/meal)
30 g ND ND CHO: 75 g Total MP, EMP (0, 2, 4, 6,
8, 12, 16, 20 and 24 h)
" CD144-EMP in T2D
v. healthy group at
baseline (P , 0·05)
and 12 h (P,0·05)
Michelsen et al. (2009)(81) Patients with atherosclerotic
plaques (echolucent (n 20)
and echogenic (n 20)) and
healthy (n 20)
Aged 56–80 years
Total n 60 (31/29)
UC HF meal (70 %E) 66 %E 32 %E 2 %E* PMP (0 and 4 h) " all groups
Fat quality: healthy subjects
Sutherland et al. (2010)(104) Healthy aged 20–70 years
n 22 (13/9)
CO, R, C HF (sunflower-seed oil)
meal (41 g) 5 g 9 g 26 g CHO: 33 g
EMP (0, 1 and 3 h) " HF (sunflower-seed oil)
compared with baseline
(P,0·05)
HF (cream) meal (41 g) 26 g 12 g 2 g CHO: 36 g
%E, percentage of energy; M, male; F, female; CO: cross-over; UC, uncontrolled; LF, low-fat; ND, not determined; Chol, cholesterol; EMP, endothelial microparticles; " , increased; HF, high-fat; R, randomised; C, controlled; CHO,
carbohydrates; MP, microparticles; BSA, body surface area; T2D, type 2 diabetics; PMP, platelet microparticles.
* Data for total PUFA.
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Table 5. Epidemiological studies investigating the associations between dietary fatty acids and vascular function
Reference
Subject group,
age and n (M/F)
Assessment of
dietary status
Fatty acid intake Vascular
function
measure Significant outcomeSFA MUFA PUFA
Cross-sectional
Sarabi et al. (2001)(85) Swedish healthy
aged 20–69 years
n 56 (31/25)
Serum lipids*
PL 0·4 (MA)
30·5 (PA)
14·4 (SA)
0·7 (POA)
12·4 (OA)
20·3 (LA) FBF Negative associations
PA in PL v. EFI (r 20·29, P,0·05)
PA in CE v. EFI (r 20·35, P,0·01)
POA in PL v. EFI (r 20·32, P,0·01)
POA in CE v. EFI (r 20·35, P,0·01)
POA in CE v. EDV (r 20·32, P,0·05)
OA in CE v. EDV (r 20·28, P,0·05)
CE 0·9 (MA)
0·2 (PDA)
11·3 (PA)
0·9 (SA)
3·7 (POA)
21·7 (OA)
50·0 (LA)
0·8 (GLA)
0·7 (DHGLA)
6·6 (AA)
Positive associations
SA in PL v. EFI (r 0·27, P,0·01)
LA in CE v. EFI (r 0·35, P,0·01)
LA in CE v. EDV (r 0·30, P,0·05)
Lind et al. (2002)(86) Same group as Sarabi
et al. (2001)(85) above
CE 0·9 (MA)
0·2 (PDA)
11·3 (PA)
0·9 (SA)
3·7 (POA)
21·7 (OA)
50·0 (LA)
0·8 (GLA)
0·7 (DHGLA)
6·6 (AA)
FBF Resting FBF v. SA (r 0·31; P,0·05)†
FBF at 80 s v. SA (r 0·41; P,0·01)†
Resting FBF v. DHGLA (r 0·32; P,0·05)†
FBF at 80 s v. DHGLA (r 20·35; P,0·05)†
Steer et al. (2003)(87) Swedish healthy
aged 20–30 years
n 74 (36/38)
Whole serum
lipids*
1·3 (MA)
25·0 (PA)
7·3 (SA)
0·2 (LAU)
34·1 (SFA)
2·9 (POA)
23·0 (OA)
26·8 (LA)
0·4 (GLA)
1·8 (DHGLA)
6·0 (AA)
LA v. EFI in males (r 20·37; P,0·05)
MA v. EFI in males (r 20·36; P,0·05)
SA v. EFI in males (r 20·31; P¼0·07)
Total SFA v. EFI in males (r 20·41; P,0·05)
Cohort
Anderson et al. (2009)(88) Adults from London
health centres
45–74 years
n 174 (89/85)
Total plasma
lipids‡
PWV PWV v. AA (r 20·25, P¼0·007)
White European 1·1 (MA)
22·0 (PA)
6·3 (SA)
3·1 (POA)
22·6 (OA)
26·0 (LA)
6·2 (AA)
1·4 (DHGLA)
Partial correlation analyses: PWV
v. AA (r 20·17; P¼0·07)
African Caribbean 0·8 (MA)
20·6 (PA)
6·4 (SA)
2·0 (POA)
19·1 (OA)
26·8 (LA)
8·0 (AA)
1·5 (DHGLA)
No differences between ethnic groups
Gujarati 1·2 (MA)
20·2 (PA)
6·4 (SA)
1·5 (POA)
17·2 (OA)
34·4 (LA)
7·2 (AA)
1·6 (DHGLA)
M, male; F, female; PL, phospholipids; MA, myristic acid; PA, palmitic acid; SA, stearic acid; POA, palmitoleic acid; OA, oleic acid; LA, linoleic acid; FBF, forearm blood flow; EFI, endothelial function index; CE, cholesteryl esters;
EDV, endothelium-dependent vasodilation; PDA, pentadecyclic acid; GLA, g-linolenic acid; DHGLA, dihomo-g-linolenic acid; AA, arachidonic acid; LAU, lauric acid; PWV, pulse wave velocity.
* Data are mean NEFA (%).
† Adjusted for age and sex.
‡ Data are weight %.
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between palmitic acid, oleic acid and linoleic acid with the
endothelial function index and EDV. Linoleic acid was posi-
tively associated with both the endothelial function index (r
0·35; P,0·01) and EDV (r 0·30; P,0·05), suggesting increased
vasodilation as a result of greater quantities of linoleic acid in
cholesteryl esters and hence, an improvement in vascular
function. In contrast, palmitic acid was negatively associated
with the endothelial function index (r 20·35; P,0·05) and
oleic acid with EDV (r 20·28; P,0·05) which implied a
decrease in vasodilation, as concentrations of these plasma
fatty acids increased in cholesteryl esters, to the detriment of
vascular function.
Data from the two longitudinal cohort studies were incon-
sistent. Although differences between the dietary fatty acid
classes and PWV were not observed in children(40), Anderson
et al.(88) reported an inverse association between the pro-
portion of arachidonic acid in total plasma lipids and arterial
stiffness (r 20·25; P¼0·007) in adults, which was independent
of ethnicity.
Dietary intervention studies investigating dietary fat
quality
Between 2000 and 2010, seven studies compared the effects of
high-fat, SFA-rich diets with either high-fat, MUFA-rich and/or
n-6 PUFA-rich diets(46,49,52,53,56,86,89) (since five of these studies
compared both dietary fat quantity and quality, they are sum-
marised separately in Table 2(46,49,52,53,56)), one study exam-
ined the effects of MUFA-rich diets only(90) and a further
study compared the effects of supplements enriched with
SFA, MUFA and n-6 PUFA(91) (Table 6). Relative to a SFA-
rich diet, a MUFA-rich diet was shown to improve vascular
function(56) or attenuate the reduction in the vascular response
observed with a SFA-rich diet(49). Similar effects on postpran-
dial vascular function were observed with MUFA-rich diets
and acute test meals, with an improvement observed by
Perez-Martinez et al.(53) and an attenuation of the reduction
in vascular response by a SFA-rich diet and test meal reported
by Fuentes et al.(52). These studies provide consistent evi-
dence that the substitution of SFA with MUFA in the back-
ground diet leads to modest improvements in vascular
function. However, the studies upon which this conclusion
is based varied in their design, and were potentially con-
founded by the effects of other dietary components such as
the quantity of fruits and vegetables, a-linolenic acid (ALNA)
and carbohydrate. As already mentioned, it should also be
noted that for two studies(52,53), measures of vascular function
were made following a test meal, the composition of which
was the same as the background diet. Since postprandial
FMD measurements have been shown to vary according to
the meal fatty acid composition, one should be cautious in
concluding that these findings result from the background
diet, rather than the fatty acids in the test meal.
Beneficial effects of MUFA-rich diets on vascular reactivity
either compared with baseline(90) or a SFA-rich meal(49,52,53,56)
cannot necessarily be attributed to the increased MUFA intake
in all of these studies. For example, Rallidis et al.(90) showed
an improvement in FMD following a Mediterranean-style
diet with intensive dietary counselling (intervention group)
compared with general advice to follow a Mediterranean-
style diet (control group). The intervention group was
shown to increase their intake of whole grains, fruits, veg-
etables, nuts, red wine and fish, in addition to extra-virgin
olive oil, which were significantly higher in total fat, MUFA,
fibre and vitamin C compared with the control group(90).
Even studies that used oil as a source of MUFA, used a variety
of oils, including extra-virgin olive oil(52,90), olive oil(56,89) and
rapeseed oil margarine and almonds(49). Additionally, the
potential impact of the polyphenolic compounds within the
extra-virgin olive oil may have influenced the results. In the
study by Keogh et al.(49), the MUFA-rich diet included rape-
seed oil-based margarine which also contains ALNA, as well
as almonds. Since almonds contain L-arginine, this may have
enhanced the bioavailability of NO and contributed to an
improvement in FMD(92). It is also difficult to determine
whether the vascular effects of replacing SFA with MUFA are
due to the increase in MUFA or simply a result of reducing
dietary SFA.
In comparison with a SFA-rich diet, only two studies
reported that MUFA-rich Mediterranean-style diets(46,89) had
no effect on vascular function. However, the lack of effect
observed by Ambring et al.(89) could have been a conse-
quence of the small difference in MUFA content between the
diets (2 %E), whereas in the study of Miller et al.(46), the con-
tribution of dietary fat of the Mediterranean South Beach diet
(17 %E) was lower than the SFA-rich Atkins diet (29·7 %E). An
additional study, which supplemented the diet with 10 g/d of
high-oleic sunflower-seed oil for 8 months, produced no effect
on ischaemic reactive hyperaemia when compared with the
SFA-rich placebo (a mixture of soyabean oil and fractionated
coconut oil)(91). However, the dosage of MUFA was relatively
low (equivalent to 1·5 g oleic acid/d) and, unlike most of the
other studies, there was no exchange of dietary SFA with
MUFA. Only one study analysed the effects of a diet rich in
both MUFA and PUFA relative to a SFA-rich diet(86). A signifi-
cant improvement in FBF was observed with the intervention
diet, but this study did not allow for conclusions to be made
on the individual classes of unsaturated fatty acids.
Only one study has compared the effects of a SFA-rich diet
with a PUFA-rich diet on vascular function, with the PUFA-rich
diet (containing ALNA) attenuating the decrease observed in
FMD with the SFA-rich diet(49) (Table 2). Limitations of this
study included the PUFA content of the diet (15·2 %E),
which was twice as high as the current recommendation in
the UK and three times higher than the population intake
recorded in the 2008–9 NDNS. In addition to this study,
Khan et al.(91) failed to show any significant changes in
ischaemic reactive hyperaemia relative to baseline following
supplementation for 8 months with 10 g/d of either n-6
PUFA-rich evening primrose oil or soyabean oil in 173 healthy
men and women. No studies to date have addressed the
impact of n-6 PUFA substitution for SFA.
Inconsistent findings were observed in the two dietary inter-
vention studies that compared the effects of high-fat, MUFA-
rich diets with PUFA-rich diets on vascular function(49,93). Of
these, a MUFA-rich diet significantly improved FMD compared
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Table 6. Chronic dietary intervention studies investigating the effects of dietary fatty acid composition on vascular function in healthy and non-healthy volunteers
Reference
Subject group, age
and n (M/F)
Study design
and duration
Description of dietary
intervention (total fat, %E)
Dietary fat composition (%E, unless specified)
Vascular
function
measure
Significant
outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Healthy volunteers
Lind et al. (2002)(86) 30–65 years (M) and
50–65 years (F)
n 19 (13/6)
CO, R, C
4 weeks
per diet
HF, MUFA- and
PUFA-rich diet (37 %E) ND ND ND
FBF " relative maximal
FBF after
MUFA/PUFA-rich
v. SFA-rich diet (P¼0·02)
HF, SFA-rich diet (37 %E) ND ND ND
Khan et al. (2003)(91) 40–65 years (PMW)
n 173 (118/55)
PAL, R, C, DB
8 months
Supplements PA/SA† OA† LA/AA/GLA† EPA/DHA/ALNA† LDI " EDV after FO
v. baseline (P¼0·02)SFA-rich placebo 64/20 166 231/0/0 0/2/34
MUFA-rich, high-oleic
sunflower-seed oil 119/75 1448 318/0/2 0/0/7
n-6 PUFA-rich EPO 79/24 146 666/0/66 0/0/22
n-6 PUFA-rich soyabean oil 171/25 327 622/0/0 0/0/112
LC n-3 PUFA-rich tuna FO 174/53 206 223/16/3 35/188/27
EPO and FO (EPO/FO) 274/56 188 418/14/78 35/197/10
Ambring et al. (2004)(89) 20–51 years
n 22 (12/10)
CO, R, C
4 weeks
per diet
CHO/fibre
(g/d)/n-3 PUFA
FBF NS
SFA-rich diet (36 %E) 17 12 ND 48/19/1 Arterial
elasticity
NS
MUFA-rich Mediterranean-style
diet (34 %E) 8 14 ND 48/40/2
Non-healthy volunteers
Ryan et al. (2000)(93) Irish Caucasian T2D
aged 40–65 years
n 11 (11/0)
UC
8 weeks per diet
n-6 PUFA-rich run-in diet ND ND ND FMD " MUFA-rich
intervention
v. PUFA run-in
diet (P,0·0001)
MUFA-rich intervention diet ND ND ND
Positive correlation with
cholesteryl ester
OA:LA ratio (r ¼ 0·61,
P,0·001)
Rallidis et al. (2009)(90) Abdominally obese with
waist circumference
.102 cm (M) and
. 88 cm (F)
, 70 years
n 82
PAL, R, C
8 weeks
Mediterranean-style diets:
(intakes estimated from
3 d food diaries)
CHO/b-carotene/
a-tocop./vitamin C
FMD " Intervention diet
v. baseline (P,0·001)
Specific food plan and close
supervision (intervention; 47·4 %E) 9·5 26·4 6·2* 38·8/595·9/4·9/167·8
" Intervention diet
v. control diet (P¼0·042)
General advice (control; 40·3 %E) 11·8 19·8 5·7* 42·1/418·4/4·4/117·1
%E, percentage of energy; M, male; F, female; CO, cross-over; R, randomised; C, controlled; HF, high-fat; ND, not determined; FBF, forearm blood flow; " , increased; PMW, postmenopausal women; PAL, parallel; DB, double
blind; PA, palmitic acid; SA, stearic acid; OA, oleic acid; LA, linoleic acid; AA, arachidonic acid; GLA, g-linoleic acid; ALNA, a-linolenic acid; LDI, laser Doppler imaging; EDV, endothelium-dependent vasodilation; FO, fish oil;
EPO, evening primrose oil; LC, long chain; CHO, carbohydrates; T2D, type 2 diabetics; UC, uncontrolled; FMD, flow-mediated dilatation; tocop., tocopherol.
* Data for total PUFA.
† Values are given as mg/10 g emulsion.
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with a run-in diet rich in n-6 PUFA and showed a significant
association between the ratio of oleic acid:linoleic acid in adi-
pocyte membranes and FMD in type 2 diabetics(93) (Table 6).
However, this study did not include another diet for compari-
son, which limits the strength of these findings. In contrast,
Keogh et al.(49) failed to find a significant difference in FMD
between groups consuming high-fat (36–37 %E), MUFA-rich
and PUFA-rich diets. It is worth noting that the source of
MUFA and PUFA varied between these studies; Ryan et al.(93)
compared diets rich in olive oil and linoleic acid, whereas
Keogh et al.(49) compared rapeseed oil margarine and PUFA-
enriched margarine, with the addition of almonds to both
diets. It is possible that the improvements in vascular function
observed by Ryan et al.(93) could be attributed, in part, to
the increased consumption of phenolic compounds in olive
oil(84). The PUFA-rich diet used by Keogh et al.(49) contained
sources of ALNA, which may explain the lack of effect
relative to the MUFA-rich diet. Therefore, no controlled
study to date has compared the impact of MUFA and n-6
PUFA on vascular function.
Effects of meal fat quality on postprandial vascular
function
Of the studies published between 2000 and 2010, ten articles
compared the effects of moderate- or high-fat meals of
differing fat composition with an equal amount or %E from
total fat on vascular function. The study by Tousoulis
et al.(74) included a comparison of different test oils with
water and therefore is summarised in Table 3, and the remain-
ing nine studies are summarised in Table 7. Substantial
differences in study design were observed between studies
(as discussed in the previous section), which make drawing
firm conclusions difficult. Of these ten studies, seven were
performed in healthy volunteers(74,94–99), one in a mixed
group of healthy and hypercholesterolaemic subjects(100) and
two in type 2 diabetics(101,102) (Tables 3 and 7).
In studies that compared the postprandial effects of SFA
with either MUFA or n-6 PUFA in healthy subjects, two studies
reported significant impairment in FMD response following
SFA-rich meals(96,99), whereas two studies observed no signifi-
cant change in FMD(94,98). However, the lack of an effect of
the SFA-rich meal on FMD response and improvement in
arterial stiffness in the study of Berry et al.(98) should be
viewed with caution since a shea butter blend, rich in stearic
acid, was used in the test meal. Stearic acid has been reported
to be neutral with respect to CVD risk due to its minimal
cholesterol-raising effects(103), and so may not be representa-
tive of all types of SFA. Furthermore, in the study by Raitakari
et al.(94), the proportion of SFA in the SFA-rich meal was much
lower than the proportion of SFA in the study by Nicholls
et al.(96), in which a detrimental effect of SFA on postprandial
vascular function was evident (48 v. 89·6 %E). Only one study
investigated the effects of SFA in individuals at high risk of
CVD and, in particular, type 2 diabetic patients(101). This
study reported a significant decline in FMD following the
SFA-rich meal (60 %E SFA), which was apparent as early as
2 h after meal ingestion and was maintained up to 6 h
postprandially, suggesting that a SFA-rich meal may have
deleterious effects on vascular function in type 2 diabetics.
Of the studies that have examined the effects of a MUFA-
rich meal or oil alone on postprandial vascular function, six
have been performed in healthy subjects and three in subjects
at high risk of CVD. In healthy subjects, three studies reported
a reduction in postprandial FMD(95,98,99), whereas the remain-
ing three studies reported no significant changes in FMD(94,97)
or FBF(74). However, in the study by Raitakari et al.(94), both
the MUFA-rich and SFA-rich control meals were shown to
enhance peripheral vasodilation assessed using FBF. The
effects of the type of MUFA-rich oil incorporated into the
test meal on vascular function were conflicting in subjects at
high risk of CVD. In the study by Corte´s et al.(100), FMD was
impaired following a meal containing olive oil (38 %E
MUFA) in both healthy and hypercholesterolaemic sub-
jects(100), whereas West et al.(102) reported an improvement
in FMD following a meal rich in high-oleic sunflower-seed
oil (50 g fat of which 32·6 g MUFA)(100,102). In contrast, no
significant alterations in FMD were observed with a meal con-
taining extra-virgin olive oil(101), or extra-virgin olive oil given
alone(74). It is highly possible that the conflicting outcomes
on the postprandial effects of MUFA on vascular function in
both healthy and non-healthy subjects may be due to the
varying sources of MUFA-rich oils used in the test meals.
Of the five studies that examined the effects of n-6 PUFA
on postprandial vascular function in healthy subjects, three
reported no significant effect on FMD(95–97), with two studies
observing an impairment in vascular function with an n-6
PUFA-rich meal(99) and n-6 PUFA-rich maize oil given
alone(74). Furthermore, in the study by Nicholls et al.(96),
the PUFA-rich meal (safflower oil, 75 %E PUFA) resulted in
an increase in post-ischaemic hyperaemia, suggesting a non-
endothelium-dependent increase in microvascular blood
flow. Interestingly, in the study of Tousoulis et al.(74), inges-
tion of soya oil alone was shown to improve reactive hyper-
aemia 1 h after ingestion, suggesting that oils rich in ALNA
and linoleic acid (maize oil) may have opposing effects on
vascular function.
In the only study performed in a mixed group of healthy
and hypercholesterolaemic subjects(100), FMD was signifi-
cantly improved in the hypercholesterolaemic individuals,
but was unchanged in healthy subjects, suggesting that
fasting lipid levels may influence the impact of the n-6 PUFA
meal in the different subject groups. However, in this study,
walnuts were the main source of PUFA, and it is not clear
whether ALNA per se or other components in walnuts (such
as L-arginine) were responsible for the observed effects. This
warrants further investigation.
Effects of meal fat quality on cellular microparticle number
Only one study has compared the effects of SFA-rich (cream)
and n-6 PUFA-rich (sunflower-seed oil) test meals on cir-
culating numbers of endothelial microparticles positive to
CD144 (a more specific marker of endothelial microparticles;
Table 4). Although ingestion of the SFA-rich meal was
associated with a greater increase in TAG concentration
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Table 7. Acute test meal studies investigating the effects of meal fatty acid composition on vascular function in healthy and non-healthy subjects
Reference
Subject group,
age and n (M/F) Study design
Description of test meal
(total fat, g or %E)
Fatty acid composition of test meal (g or %E)
Vascular function
measure
(time points) Significant outcomesSFA MUFA
n-6 PUFA
(PUFA*) Other
Healthy subjects
Vogel et al. (2000)(95) 28–55 years
n 10 (5/5)
CO, R, C HF OO meal (50 g) ND ND ND FMD
(0 and 3 h)
# OO meal v. baseline (P¼0·008)
HF rapeseed oil meal (CO) (50 g) ND ND ND
HF salmon meal (S) (50 g) ND ND ND
Raitakari et al. (2000)(94) 18–45 years
n 12 (7/5)
CO, C HF SFA meal (61 g) 48 %E 40 %E 7·4 %E* Trans FA: 4·6 %E FMD
FBF
(0, 3 and 6 h)
" resting FBF (P,0·001) and
stimulated FBF (P,0·001)
after both meals
HF MUFA meal (61 g) 10 %E 85 %E 5 %E* Trans FA: 0 %E
Williams et al. (2001)(97) 23–53 years
n 14 (14/0)
CO, R, C, DB OO-rich drink (78·4 g) 18 g 40·7 g 9·5 g* CHO: 62·5 g;
Chol: 210 mg
FMD
(0 and 4 h)
NS
SO-rich drink (78·4 g) 12·4 g 11·1 g 44·1 g* CHO: 62·5 g;
Chol: 210 mg
Nicholls et al. (2006)(96) 18–40 years
n 14 (8/6)
CO, R, C, DB SO-rich meal (1 g fat/kg BW) 8·8 %E 13·6 %E 75·0 %E FMD
FBF
(0, 3 and 6 h)
# 3 h after CO meal (P,0·05)
" post-hyperaemic FBF after
SO meal (45 %) and CO meal
(21 %) (P¼0·02)
Coconut oil-rich meal
(CO) (1 g fat/kg BW) 89·6 %E 5·8 %E 1·9 %E
Rueda-Clausen
et al. (2007)(99)
18–23 years
n 10 (10/0)
CO, R, C, DB Soup with OO 14·3 % 77·8 % 6·55 %* CHO: 50·6 kcal FMD
(0 and 3 h)
# all meals (P , 0·00001)
Soup with palm oil 43·6 % 46·4 % 9·97 %* CHO: 50·6 kcal
Soup with soyabean oil 16·3 % 24·4 % 52·78 %* CHO: 50·6 kcal
Berry et al. (2008)(98) 18–40 years
n 17 (17/0)
CO,R HF stearic acid-rich meal (50 g) 26·7 g 16·4 g 4·5 g CHO: 89 g FMD
PWV
# FMD 3 h after oleic acid-rich
meal v. baseline (P,0·001)HF oleic acid-rich meal (50 g) 0·8 g 42·5 g 4·0 g CHO: 89 g
PWA
(0 and 3 h)
# PWA and PWV 3 h after both
meals v. baseline (P,0·001)
Healthy and non-healthy subjects
West et al. (2005)(102) T2D aged
55 ^ 2 years
n 18 (13/5)
CO, R, C, DB CHO/ALNA/EPA/DHA
MUFA meal (50 g) 4·5 g 32·6 g 9·2 g 24 g/0·5 g/0 g/0 g FMD
(0 and 4 h)
" all meals (P¼0·01)
MUFA meal with ALNA (50 g) 3·5 g 31·2 g 9·2 g 24 g/3·3 g/0 g/0 g Inverse correlation between
D in TAG and D in FMD
(r ¼ -0·50, P,0·05) with
the MUFA meal
MUFA meal with EPA/DHA (50 g) 5 g 30·7 g 6·1 g 24 g/0·2 g/2·8 g/1·2 g
" TAG associated with
" FMD (r ¼ 0·49, P¼0·046
and r ¼ 0·49, P¼0·052) after
MUFA meals with ALNA
and EPA/DHA
Corte´s
et al. (2006)(100)
HC aged
45 ^ 13 years
n 12 (11/1)
CO, R CHO/ALNA/Chol
HF OO meal (80 g) 35 %E 38 %E 7 %E* 22 %E/0 g/120 mg FMD
(0 and 4 h)
# OO meal v. baseline in
healthy and HC subjects
Healthy controls
aged 32 ^ 8 years
n 12 (9/3)
HF walnut meal (80 g) 35 %E 23 %E 23 %E* 22 %E/5·4 g/120 mg " in HC group after
walnut meal (P¼0·006)
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within the chylomicron-enriched fraction at 1 and 3 h post-
prandially, the n-6 PUFA-rich meal led to higher circulating
levels of endothelial microparticles compared with the SFA-
rich meal. It has been proposed that the fat content of a test
meal may increase the numbers of circulating endothelial
microparticles as a result of the increased lipaemia. However,
the findings from this study suggest that the fatty acid compo-
sition of a test meal may also play an important role in the
shedding of endothelial microparticles positive to CD144
during the postprandial state(104).
Summary
There is, at present, insufficient epidemiological evidence
(three cross-sectional studies and two longitudinal cohort
studies) to draw any firm conclusions on the association
between dietary fat composition and vascular function.
There are a number of limitations of published studies, includ-
ing study size, relevance of the population studied and
methods of assessment of vascular function.
Data were also limited on which to draw conclusions
regarding the chronic effects of dietary fatty acid composition
on measures of vascular function. However, there is moder-
ately consistent evidence to suggest a small improvement in
vascular function when MUFA-rich diets were compared
with SFA-rich diets in healthy and non-healthy individuals,
whereas data regarding the effects of n-6 PUFA diets are extre-
mely limited. The current data suggest that a reduction in diet-
ary SFA may have beneficial effects on vascular function,
and that a MUFA-rich diet may provide an alternative to the
low-fat, high-carbohydrate diet.
For the test meal studies, there was weak evidence to
suggest a modest reduction in vascular function following a
SFA-rich meal, whereas inconsistent effects were observed
with both MUFA-rich and PUFA-rich meals. Nevertheless,
meal fatty acid composition has previously been shown to
exert differential effects on plasma lipids and other metabolic
measures that might be responsible for these findings. To date,
only one study has examined the impact of meal fatty acid
composition on circulating levels of endothelial microparti-
cles, with no data available on endothelial progenitor cells
or platelet microparticles.
Conclusions
A systematic approach was used to review the literature on the
impact of both the quantity and quality of specific dietary fats
(SFA, MUFA and n-6 PUFA) on vascular function and circulat-
ing levels of cellular microparticles. The role of n-3 PUFA
was not considered in the present review as the effects of
this class of fatty acids on vascular function, including poten-
tial mechanisms of action, have been covered in depth else-
where(15,19,28,105). Few studies were designed to directly
compare the substitution of SFA with MUFA and n-6 PUFA
on vascular function, with the majority comparing diets/
meals rich in SFA, MUFA or PUFA. The measurement of
novel biomarkers of vascular function such as endothelial
progenitor cells, endothelial microparticles and plateletTa
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microparticles was also extremely limited, especially after
meals of differing fatty acid composition. Differences in the
designs of both the chronic intervention and postprandial
test meal studies rendered comparisons difficult. In particular,
studies of the effects of high-fat, MUFA-rich diets used either a
combination of MUFA-rich oils or complex dietary strategies
such as the Mediterranean diet. The majority of the studies
investigating the chronic and postprandial effects of PUFA
used diets/meals that contained a mixture of both n-3
(ALNA) and n-6 PUFA.
The nature and health status of subjects and the method of
assessment of vascular function were other variables that
could have influenced outcome. Men were the most fre-
quently investigated group. However, when premenopausal
women were included, no consideration was given to the
potential impact of the menstrual cycle phase and sex hor-
mone concentrations on vascular function measures. FMD
was used in the majority of studies, while FBF, arterial stiffness
(PWV/PWA and DVP) and reactivity of the peripheral micro-
circulation (LDI) were used in a smaller number of studies.
These techniques evaluate a diverse range of vascular end-
points, which makes the comparison of the data from the
various studies difficult, since the reactivity of the macro-
and microcirculation is known to be influenced by different
physiological factors. Some studies failed to include a suitable
control or comparator group, and two studies were of a mixed
design, incorporating both a dietary intervention and post-
prandial test meal protocol. There were also issues relating
to the type of statistical analysis performed, with very few
studies investigating how the intervention diet(s) influenced
the measure of vascular function over the time course of
the study.
In conclusion, there is a requirement for suitably powered,
robust randomised controlled trials to investigate the substi-
tution of dietary SFA with both MUFA and n-6 PUFA on vascu-
lar function in adults. A dose–response study design would
provide strong evidence for the effects (or lack) of dietary
fats on vascular function. With the increased prevalence of
obesity within the population, future studies should not only
be conducted in healthy adults but also in adults at increased
cardiometabolic risk, using well-standardised measures of vas-
cular function. Future test meal studies should consider exam-
ining meals with a fat content that is more reflective of
habitual eating patterns. Data from controlled and sufficiently
powered investigations, in targeted populations, will be essen-
tial to enable development of the optimum dietary strategy to
reduce SFA intake in the diet.
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